Add like
Add dislike
Add to saved papers

Randomized controlled trial comparing open simple Prostatectomy or Prostate Artery Embolization in large prostates: clinical and urodynamic assessment - PoPAE study.

Urology 2024 April 31
OBJECTIVE: To evaluate the effects of PAE and Open Simple Prostatectomy (OP) on LUTS and urodynamic parameters in subjects with prostate size > 80 cc³.

METHODS: PoPAE study (open simple Prostatectomy or Prostate artery embolization) was a randomized, open-label controlled trial performed between January 2020 and May 2022.Subjects with large prostates (> 80cc³), urodynamic parameters meeting obstruction criteria (Bladder Outlet Obstruction Index - BOOI > 40), and good detrusor function (Bladder contractility index>100) were included. The primary and co-primary endpoints were the variation in peak flow rate on uroflowmetry (Qmax) and BOOI. The secondary endpoints were the IPSS and ultrasonographic changes.

RESULTS: 23 and 25 subjects underwent PAE and OP were evaluated, respectively. At baseline, the 2 groups have shown similar clinical, radiological, laboratory, and urodynamic parameters.After 6 months, Qmax improved 8,3 ± 4.17 ml/sec in PAE and 15.1 ± 8.04 ml/sec in OP(mean difference 6.78 in favor of PE; p=0.012 [CI -9.00 to -3.00]). After treatment, 88 % of those men underwent OP were classified as unobstructed or equivocal (BOOi<40). On the other hand, 70% of subjects underwent PAE remained obstructed (BOOI>40) and none of them shifted to unobstructed status (BOOI<20). It was observed a similar reduction in IPSS and PVR in both groups.

CONCLUSION: PAE was inferior to conventional surgery for releasing BOO and improving peak urinary flow in large prostates. Nevertheless, PAE was able to improve symptoms and PVR, and might be an alternative method in selected patients.

Full text links

We have located links that may give you full text access.
Can't access the paper?
Try logging in through your university/institutional subscription. For a smoother one-click institutional access experience, please use our mobile app.

Related Resources

For the best experience, use the Read mobile app

Mobile app image

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

By using this service, you agree to our terms of use and privacy policy.

Your Privacy Choices Toggle icon

You can now claim free CME credits for this literature searchClaim now

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app